APA (7th ed.) Citation

IA, V., M, C., J, V., C, C., S, M., L, P., . . . G, R. (2026). Case Report: Niraparib-abiraterone in HRR-mutated metastatic castration-resistant prostate cancer: clinical insights from five cases. Frontiers in oncology, 16, 1799304. https://doi.org/10.3389/fonc.2026.1799304

Chicago Style (17th ed.) Citation

IA, Vascotto, et al. "Case Report: Niraparib-abiraterone in HRR-mutated Metastatic Castration-resistant Prostate Cancer: Clinical Insights from Five Cases." Frontiers in Oncology 16 (2026): 1799304. https://doi.org/10.3389/fonc.2026.1799304.

MLA (9th ed.) Citation

IA, Vascotto, et al. "Case Report: Niraparib-abiraterone in HRR-mutated Metastatic Castration-resistant Prostate Cancer: Clinical Insights from Five Cases." Frontiers in Oncology, vol. 16, 2026, p. 1799304, https://doi.org/10.3389/fonc.2026.1799304.